Patents by Inventor Susana MARTÍN GARCÍA

Susana MARTÍN GARCÍA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Porcine reproductive and respiratory syndrome virus cDNA clone and uses thereof
    Patent number: 11332739
    Abstract: The present invention relates to a method for preparing cDNA infectious clones based on the genome of an attenuated Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and uses thereof for preparing efficacious and safety-enhanced vaccines against PRRSV. The invention further comprises an infectious cDNA clone obtainable by such method. The invention further provides an attenuated modified PRRSV, and immunogenic compositions and vaccines comprising that attenuated PRRSV. The present invention further provides the attenuated PRRSV for use in the prophylaxis and/or the treatment of PRRSV infections, and the attenuated PRRSV for use as vaccine or medicament in the prophylaxis and/or the treatment of PRRSV infections.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: May 17, 2022
    Assignees: HIPRA SCIENTIFIC, S.L.U., CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
    Inventors: Xavier Gibert Pérez, Marta Sitjà Arnau, Maria Mar Fenech Martínez, Santiago Francisco Elena Fito, Susana Martín García
  • PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS cDNA CLONE AND USES THEREOF
    Publication number: 20190177721
    Abstract: The present invention relates to a method for preparing cDNA infectious clones based on the genome of an attenuated Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and uses thereof for preparing efficacious and safety-enhanced vaccines against PRRSV. The invention further comprises an infectious cDNA clone obtainable by such method. The invention further provides an attenuated modified PRRSV, and immunogenic compositions and vaccines comprising that attenuated PRRSV. The present invention further provides the attenuated PRRSV for use in the prophylaxis and/or the treatment of PRRSV infections, and the attenuated PRRSV for use as vaccine or medicament in the prophylaxis and/or the treatment of PRRSV infections.
    Type: Application
    Filed: July 31, 2017
    Publication date: June 13, 2019
    Applicants: Hipra Scientific, S.L.U., Consejo Superior de Investigaciones Cientificas (CSIC)
    Inventors: Xavier GIBERT PÉREZ, Marta SITJÀ ARNAU, Maria Mar FENECH MARTÍNEZ, Santiago Francisco ELENA FITO, Susana MARTÍN GARCÍA